Waterdrop (NYSE:WDH) Raised to Buy at Wall Street Zen

Waterdrop (NYSE:WDH) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings cut shares of Waterdrop from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, October 2nd. One analyst has rated the stock with a Sell rating. According to MarketBeat, the company presently has an average rating of “Sell”.

Waterdrop Stock Down 0.5%

Shares of Waterdrop stock opened at $1.00 on Friday. Waterdrop has a 52 week low of $0.96 and a 52 week high of $2.03. The business’s fifty day simple moving average is $1.02 and its 200-day simple moving average is $1.38. The firm has a market cap of $362.69 million, a PE ratio of 4.79 and a beta of -0.24.

Waterdrop (NYSE:WDH) last issued its quarterly earnings data on Tuesday, September 8th. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $213.16 million during the quarter. Waterdrop had a return on equity of 10.47% and a net margin of 10.69%.

Hedge Funds Weigh In On Waterdrop

A hedge fund recently bought a new stake in Waterdrop stock. Renaissance Technologies LLC acquired a new position in shares of Waterdrop Inc. Unsponsored ADR (NYSE:WDH) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 57,957 shares of the company’s stock, valued at approximately $94,000. Institutional investors own 1.96% of the company’s stock.

Waterdrop Company Profile

Waterdrop Inc is a technology platform focused on insurance services and healthcare support in China. Through its online insurance marketplace, the company helps consumers compare and purchase insurance products, while providing insurers with digital distribution and customer-engagement services.

The company also operates Waterdrop Crowdfunding, an online medical expense fundraising platform intended to help individuals and families seek financial assistance for treatment-related costs.